rejuvant life tabs

Longevity supplements report: Juvenescence profile

Latest articles

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...
Rejuvant

Ahead of the launch of its first major product, Metabolic Switch, we take a look at Juvenescence.

Over the coming weeks, we will be bringing you extracts of 11 company profiles from our Longevity Supplements Report. Each profile includes an assessment of Pre-Clinical and Clinical Studies, Safety and Risks, Target Market and Success Factors and the target Hallmark(s) of Aging for one of their key products.

We also study each of the companies’ IP, team, UVP, product efficacy, competitive advantage, runway and inflection point, and much more. Here’s the lowdown on Juvenescence.

To view a full size version of Juvenescence’s profile please click here.

Longevity Supplements 1.0 Juvenescence Summary
.

All about Juvenescence

Juvenescence was founded with a mission to transform what aging means to the world. As the science around aging was starting to accelerate, Juvenescence saw an opportunity to further that science by encouraging collaboration between leading scientists, physicians and investors to create new therapies and products that they hope will empower people to look after their own health. Juvenescence presents a modality-agnostic portfolio of therapies developed by seasoned drug developers and augmented by machine learning.

Juvenescence plans to transform aging and has organised itself into four major divisions, each of which tackles the topic from a different scientific angle: JuvRx focuses on drug therapies; JuvRegeneration spotlights stem cell regeneration; JuvDataScience applies machine learning and AI; and JuvLife emphasises non-prescription IP protected therapies with clinical proof focused on disease prevention.

Elevant

Metabolic Switch

Juvenescence was founded by three scientist/investors with long-proven track records in healthcare market: Chairman, Jim Mellon, is a Trustee at the Buck Institute for Research on Aging and author of the book, Juvenescence: Investing in the Age of Longevity (2017); CEO, Dr Greg Bailey, is a serial bio-tech entrepreneur as co-founder or director at Portage Biotech, Biohaven, Medivation, Ascent Healthcare Solutions and VirnetX Inc.; CMO, Dr Dec Doogan, has already had a long and successful career including SVP-WW Drug Development at Pfizer and as CEO of Amarin. The founders of Juvenescence have created an impressive $26 billion of biopharma shareholder value in the past two decades. As CEO, Dr Greg Bailey has stated: “Juvenescence will be an innovative 21st century biotech company. We will focus on disruptive technologies to prevent or delay age-related disease or to modify aging. We incorporate machine learning, social media and a direct relationship with our patients and consumers to empower and facilitate healthy long life.”

JuvLife is the division of Juvenescence that will focus on creating consumer products that are readily available to manage aging and enhance healthspan. Juvenescence anticipates that JuvLife will quickly become established as the trusted source for high quality, science-based, consumer products. These non-Rx products and functional foods are aimed at supporting individuals as they manage their own health and the onset of age-related conditions. “We are determined to become the trusted source for not only high-quality science-based products but helping everyone better understand aging and how to improve their healthspan and lifespan.”

JuvLife has announced that it will be launching its first major product, branded Metabolic Switch Ketone Ester Fuel, in 2021. Each serving of C6 Ketone Di-Ester naturally raises the level of ketones in the blood to quickly generate a state of ketosis that lasts for several hours. Metabolic Switch was invented by scientists at the Buck Institute for Research on Aging and developed in partnership with the team at Juvenescence. It will be available firstly as a chocolate-flavoured nitro beverage, but additional forms, flavours and variants of the product will also be made available as the product line expands. JuvLife is currently finalising clinical studies and other aspects of commercial scale up for Metabolic Switch, and the company expects GRAS approval of the product in 2021.

Elevant

Access to the report and a FREE executive summary can be found here, and check out our other supplements company profiles here.

Comment on this article

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

Gerostate Alpha opens crowdfunded capital raise

Buck Institute-founded start-up Gerostate Alpha seeks to crowdfund its biotech platform. When Y Combinator so likes your ideas, it gives you $1 million to start...

Can leucine turbo-charge longevity supplements and drugs?

Our exclusive interview with NuSirt’s founder explores how combining the sirtuin-activating amino acid has the potential to enhance the effect of longevity supplements and...

FOXO announces $10million investment to launch FOXO Life

FOXO Technologies Inc announces closing of $10 million investment to launch FOXO Life; continues commercialising epigenetic biomarker technology. FOXO Technologies Inc has announced that it...
Supps report ad middle